default author photo

Su Pin Choo

National Cancer Centre Singapore - Division of Medical Oncology

Singapore

SCHOLARLY PAPERS

3

DOWNLOADS

506

TOTAL CITATIONS

6

Scholarly Papers (3)

1.

Nivolumab Versus Sorafenib Treatment in Advanced Hepatocellular Carcinoma (CheckMate 459): A Randomised, Multicentre, Open-Label, Phase 3 Trial

Number of pages: 47 Posted: 16 Aug 2021
The University of Hong Kong, National Cancer Center, Korea, University of California, Los Angeles (UCLA) - David Geffen School of Medicine, National Taiwan University - Department of Internal Medicine, Anger University Hospital - HepatoGastroenterology Department, Centre Eugène Marquis - Medical Oncology, Kindai University - Department of Gastroenterology and Hepatology, Memorial Sloan Kettering Cancer Center - Department of Medicine, Croix Rousse Hospital - Hepatology Unit, Sorbonne University - ssistance Publique Hôpitaux de Paris, M. Sklodowska-Curie Memorial National Cancer Research Institute, University Hospital Ulm - Helios Klinikum Emil von Behring GmbH, National Cancer Centre Singapore - Division of Medical Oncology, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, Medical University of Vienna - Department of Internal Medicine III, Hôpital Avicenne (APHP) - Centre Hospitalier Universitaire de Montpellier,, Medical University of Gdańsk - Department of Clinical Oncology and Radiotherapy, Kyorin University - Department of Medical Oncology, Memorial Sloan Kettering Cancer Center - Department of Medicine, University of Southern California - Norris Comprehensive Cancer Center, University of Navarra - Department of Cardiology and Cardiovascular Surgery, Bristol Myers Squibb, Bristol Myers Squibb, Bristol Myers Squibb, Bristol Myers Squibb, Bristol Myers Squibb and Carlos III National Institute of Health - Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd)
Downloads 241 (316,532)
Citation 6

Abstract:

Loading...

hepatocellular carcinoma, liver cancer, nivolumab, PD-1 inhibitor, sorafenib, immuno-oncology, CheckMate

2.

A Phase II Trial of Y90-Resin Microspheres Radioembolization Followed by Nivolumab in Advanced Hepatocellular Carcinoma– CA 209-678

Number of pages: 39 Posted: 01 Sep 2021
National Cancer Centre Singapore - Division of Medical Oncology, National University of Singapore (NUS) - Department of Nuclear Medicine and Molecular Imaging, National University of Singapore (NUS) - Singapore General Hospital, Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, National Cancer Centre Singapore, National Cancer Centre Singapore, Singapore General Hospital - Nuclear Medicine and Molecular Imaging, National University of Singapore (NUS) - Singapore General Hospital, National Cancer Centre Singapore, Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, National University of Singapore (NUS) - Singapore General Hospital, National Cancer Centre Singapore - Division of Medical Oncology, National Cancer Centre Singapore, National Cancer Centre Singapore, National Cancer Centre Singapore, National Cancer Centre Singapore, National University of Singapore (NUS) - Singapore General Hospital, National University of Singapore (NUS) - Singapore General Hospital, National University of Singapore (NUS) - Singapore General Hospital, Singapore General Hospital - Vascular and Interventional Radiology, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, National Cancer Centre Singapore - Division of Medical Oncology, National Cancer Centre Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery and National Cancer Centre Singapore - Division of Medical Oncology
Downloads 185 (409,459)

Abstract:

Loading...

Hepatocellular carcinoma, Y90-resin microspheres radioembolization, nivolumab

3.

Distinct Tumor-Resident Memory HBV-Specific T Cell Responses Correlate with Relapse-Free Survival in Patients with HBV-Associated Hepatocellular Carcinoma

Number of pages: 96 Posted: 05 Jan 2021
Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, St. Jude Children’s Research Hospital - Department of Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, St. Jude Children’s Research Hospital - Department of Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital - Department of Hepatopancreatobiliary and Transplant Surgery, KK Women’s and Children’s Hospital - Department of Reproductive Medicine, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Cancer Centre Singapore - Division of Medical Oncology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National University Health System (NUHS) - Division of Gastroenterology and Hepatology, Agency for Science, Technology and Research (A*STAR) - Genome Institute of Singapore, National Cancer Centre Singapore - Division of Medical Oncology and University of Washington - Department of Laboratory Medicine and Pathology
Downloads 80 (803,225)

Abstract:

Loading...